Home

Press Releases

2013

May 15GeneNews Reports Q1 2013 Financial Results
Apr 15GeneNews Announces Annual Shareholder Meeting
Mar 26GeneNews Reports Q4 and Full Year 2012 Financial Results
Feb 22GeneNews Extends Term of Certain Warrants
Jan 16GeneNews to Hold Shareholder Meeting

2012

Dec 21GeneNews Implements Share Consolidation
Dec 14GENENEWS RAISES MORE THAN $7.5 MILLION IN NON-BROKERED PRIVATE PLACEMENT
Dec 7GeneNews Announces Proposed Non-Brokered Private Placement and Implementation of Share Consolidation
Nov 12GeneNews Reports Third Quarter 2012 Financial Results
Sep 28GeneNews to Present at AdvaMed 2012
Sep 25GeneNews and Shanghai Biochip Enter Into Strategic Alliance
Aug 9GeneNews Reports Second Quarter 2012 Financial Results
Jun 19GeneNews Attending 2012 BIO International Convention
Jun 12GeneNews Completes Rights Offering
Jun 1GeneNews Presents Novel Biomarker Panel for Liver Cancer at ASCO 2012
May 29GeneNews to Present at BioFinance 2012
May 11GeneNews Reports First Quarter 2012 Financial Results
Apr 26GeneNews Shareholders Approve Share Consolidation and Extension of Term for Certain Warrants
Apr 18GeneNews Announces Rights Offering
Apr 16GeneNews to Present Liver Cancer Data at ASCO 2012
Apr 10GeneNews' First U.S. Marketing Partner Launches ColonSentry®
Mar 25GeneNews Reports Fourth Quarter and 2011 Annual Results
Feb 21GeneNews' US Partner Obtains Approval to Market ColonSentry®
Feb 6GeneNews Enters Into MOU With Shanghai Biochip to Establish First Sentinel Centre for Personalized Medicine

2011

Dec 23GeneNews Extends Term of Certain Warrants
Nov 10GeneNews' Sentinel Principle® Used to Discover New Blood Based Biomarkers for Nasopharyngeal Carcinoma
Nov 9GeneNews Diagnostics Launches ColonSentry in Malaysia
Oct 31GeneNews Shareholders Approve Proposed Share Consolidation
Oct 27GeneNews Announces SentinelGx™ Pharmacogenomic and Companion Diagnostic BloodRNA™ Service
Oct 27GeneNews Reports Third Quarter 2011 Financial Results
Oct 12GeneNews' Sentinel Principle® Used to Discover New Blood Based Biomarkers for Schizophrenia
Sep 20GeneNews Limited Announces Proposed Share Consolidation
Aug 10GeneNews Reports Second Quarter 2011 Financial Results
Jul 15Sentinel Principle® used to discover blood based biomarkers to predict risk of liver cancer from patients with chronic hepatitis
Jun 9GeneNews Closes Warrant Exercise and Debenture Conversion Programs
May 18GeneNews Reports First Quarter 2011 Financial Results
May 17GeneNews Limited Announces Approval of Early Warrant Exercise Incentive Program and Conversion Opportunity for Debentureholders
Apr 18GeneNews Limited Announces Early Warrant Exercise Incentive Program and Conversion Opportunity for Debentureholders
Mar 25GeneNews Reports Fourth Quarter and 2010 Annual Results

2010

Nov 16GeneNews to Present at Dundee Capital Markets Emerging Growth Conference in Toronto
Nov 15GeneNews Reports Third Quarter 2010 Financial Results and Provides Update on Recent Events
Nov 9GeneNews Raises $2.1 Million
Nov 2ColonSentry Commercialization Supported by Seed Capital Grant from Malaysia Biotech Corp.
Aug 24New Study Demonstrates Value of ColonSentry™ as Pre-screening Alert to Enhance Effectiveness of Colorectal Cancer Screening
Aug 10GeneNews Reports Second Quarter 2010 Financial Results
Jun 29GeneNews Executes Marketing Partnership Agreement with GeneDiagnostics
Jun 3Malaysian Study Further Validates GeneNews' ColonSentry™ Test
May 18GeneNews Partners with GeneDiagnostics Inc. to Market ColonSentry™ in China
May 11GeneNews Issued U.S. Patents for Schizophrenia and Osteoarthritis Based on Core Sentinel Principle® Platform
May 5GeneNews to Feature ColonSentry™ at the 8th Annual Primary Care Today Conference
May 4GeneNews Reports First Quarter 2010 Financial Results
May 4GeneNews Announces Board and Management Changes
Apr 5GeneNews to present at BioFinance 2010
Mar 15GeneNews Reports Fourth Quarter and 2009 Annual Results
Feb 16GeneNews announces issuance of second foundational U.S. patent for core Sentinel Principle® technology
Feb 9GeneNews provides corporate and ColonSentry™ commercialization update
Jan 11GeneNews to Present at OneMedPlace Financial Forum

2009

Dec 22GeneNews Raises More Than $2 Million in Non-Brokered Private Placement
Dec 9GeneNews announces proposed non-brokered private placement
Nov 18GeneNews partners with Enzo Clinical Labs to market ColonSentry™ in the U.S.
Nov 11GeneNews announces third quarter results
Oct 27GeneNews provides Lilly with access to its osteoarthritis biomarker program
Oct 22GeneNews announces Sentinel Principle® used to discover new blood based biomarkers for Crohn's disease
Oct 6GENENEWS ANNOUNCES U.S. ISSUANCE OF CORE SENTINEL PRINCIPLE® PATENT
Oct 1GeneNews publishes positive ColonSentry™ validation data in leading International Cancer Journal
Aug 14GeneNews announces second quarter results
Aug 10GeneNews completes non-brokered private placement
Jul 9GeneNews closes first tranche of non-brokered private placement
May 14GeneNews announces first quarter results
May 6GeneNews announces Dundee Wealth to offer ColonSentry™ to its employees
Apr 29GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government
Apr 8GeneNews Appoints Dr. David Sable to Board of Directors
Apr 6GeneNews presents results of study on cost-effectiveness of ColonSentry™ for colorectal cancer screening
Apr 1GeneNews Announces 2008 Year End Results
Feb 18GeneNews Expands Availability of ColonSentry™ in Southwestern Ontario
Feb 10GeneNews Announces Third Tranche of Debenture Offering
Jan 20GeneNews Announces Management Changes
Jan 16GeneNews Announces Second Tranche of Debenture Offering
Jan 13GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle™ platform
Jan 12GeneNews’ ColonSentry™ Test Featured in Canadian Medical Journal

2008

Dec 31GeneNews Announces Issuance of Debentures
Dec 11GeneNews Provides Centocor Access to its Osteoarthritis Program
Nov 25GeneNews to exhibit ColonSentry™ at Family Medicine Forum 2008
Nov 19GeneNews Rolls Out ColonSentry™ Test In Additional Toronto Area Labs
Nov 18GeneNews Appoints Canadian Colorectal Cancer Advisory Board
Nov 17GeneNews Announces 2008 Third Quarter Results
Nov 12GeneNews Restructures Operations
Oct 14GeneNews Appoints Patrick Terry as Lead Strategic Advisor for U.S Commercialization of ColonSentry™
Aug 12GeneNews Partners with Leading Executive Health Clinic for Colonsentry™
Aug 7GeneNews Announces Second Quarter Results
Jul 20GeneNews Launches World's First Blood Test for Colorectal Cancer Screening
Jun 2GeneNews Announces Management Changes to Support Commercialization of ColonSentry™
May 5GeneNews Adds Two Members To Its Board Of Directors
May 2GeneNews Announces 2008 First Quarter Results
Apr 14GeneNews Reports Positive Results From Validation Study of Colorectal Cancer Biomarkers in Late Breaking Abstract at AACR
Mar 26GeneNews Announces 2007 Year End Results
Mar 17Genenews Selected To Present Late-breaking Abstract At AACR Annual Meeting
Mar 10GeneNews Receives ISO 13485 Accreditation
Jan 15GeneNews Publication Confirms Blood-Based Colorectal Cancer Biomarker Results
Jan 7GeneNews Appoints Three Leading Cancer Screening Experts to its Clinical Advisory Board

2007

Dec 17GeneNews Initiates Patient sample Accrual For Validation Studies of Colon Cancer Blood Test
Dec 4Moving Towards Improved Colon Cancer Detection
Nov 8GeneNews Reports Third Quarter 2007 Results
Oct 16GeneNews Relocates To New Facility
Aug 29GeneNews Chief Scientist Dr. C.C. Liew Co-Editor of New Genomics Reference Book
Aug 19Dr. C.C. Liew Awarded State Honour by the Government of Malaysia
Aug 14Genenews Reports Second Quarter 2007 Results
Aug 13Genenews Secures $2 Million for Development of Prostate Biomarkers
Jul 25Genenews Forms Clinical Advisory Board for its Colorectal Cancer Blood Test
May 16GeneNews Reports First Quarter 2007 Financial Results
Apr 11Genenews Announces Management Changes
Mar 30Genenews Reports 2006 Year End and Fourth Quarter Financial Results
Jan 10GeneNews Management Update

2006

Nov 15GeneNews Appoints Dr. Roman Zastawny VP Biomarker Development
Nov 8GeneNews Reports Third Quarter 2006 Financial Results
Oct 31GeneNews to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference
Oct 26GeneNews Receives Frost & Sullivan Award to Recognize the Sentinel Principle
Oct 25GeneNews to Begin Trading on TSX on October 26, 2006
Oct 23ChondroGene Announces Name Change to GeneNews
Sep 22ChondroGene Receives Conditional Approval to Trade on the Toronto Stock Exchange
Sep 20ChondroGene Announces the Issuance of Stock Options
Sep 19Molecular Diagnostics Industry Executive, Dr. Heiner Dreismann, Joins ChondroGene's Board
Aug 17ChondroGene Reports Second Quarter 2006 Financial Results
Jul 21ChondroGene's Dr. Daniel H. Farkas Chairs and Opens American Association of Clinical Chemistry Annual Meeting
Jul 20ChondroGene Presenting at 11th Annual Society of Chinese Bioscientists in America Meeting
Jun 19Application of Sentinal Principle in Bladder Cancer Published in Clinical Cancer Research
Jun 7Blood-Based Detection of Colon and Prostate Cancer Abstracts Presented at American Society of Clinical Oncology Annual Meeting
May 31ChondroGene Reports First Quarter 2006 Financial Results
May 26Chondrogene Announces Completion of $25 Million Private Placement Financing
May 12ChondroGene Announces $20 Million Bought Deal Private Placement Financing
May 10ChondroGene Appoints Dave Tyler Director, Product Development and Quality Assurance
May 1ChondroGene to Present at BioFinance 2006
Apr 27ChondroGene Enters Into A Collaborative Research Study with Kaiser Permanente
Apr 25Colon and Prostate Cancer Abstracts Accepted by American Society of Clinical Oncology
Mar 23ChondroGene to sponsor and present at medical biotechnology symposium in Malaysia
Mar 22ChondroGene reports on blood-based prostate cancer diagnostic test development
Mar 10Sentinel Principle™ paper published in Journal of Laboratory and Clinical Medicine
Mar 9ChondroGene reports 2005 fourth quarter and year end financial results
Feb 22ChondroGene reports on blood-based colon cancer test development

2005

Dec 1ChondroGene appoints Dr. Daniel H. Farkas VP Clinical Diagnostics
Nov 30ChondroGene Announces the Issuance of Stock Options
Nov 17ChondroGene reports third quarter 2005 financial results
Nov 16Application of Sentinel Principle™ in schizophrenia paper published in Proceedings of National Academy of Science
Nov 3ChondroGene to present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
Nov 1ChondroGene Limited company information available through S&P Market Access Program
Oct 28ChondroGene Enters Into Agreement with Kaiser Permanente
Oct 25Blood-based Osteoathritis Biomarker Paper Published
Aug 12ChondroGene announces TSX-V approval of Amended Stock Option Plan and the issuance of stock options
Aug 12ChondroGene reports second quarter 2005 financial results
Aug 10ChondroGene Enters into a Broad Alliance with UCSF
Jun 10ChondroGene Enters into Clinical Collaborations with Two Malaysian Hospitals
May 17Blood-based Biomarkers Used to Detect Bladder Cancer
May 16ChondroGene reports first quarter 2005 financial results
Apr 6Chondrogene Reports 2004 Fourth Quarter and Year End Financial Results
Mar 16ChondroGene Receives Funding Support from NCR-IRAP to Develop a Blood-Based Osteoarthritis Test
Jan 19Psychiatric Disorders Detected Using Blood Test

2004

Dec 21ChondroGene and Pfizer Enter into a New Osteoarthritis Collaboration
Nov 26ChondroGene Announces the Issuance of Stock Options
Nov 24ChondroGene Reports Third Quarter 2004 Financial Results
Nov 15ChondroGene Receives Third Pfizer Milestone Payment
Sep 13ChondroGene Completes US$500,000 Private Placement Through PowerOne Capital Markets Limited
Aug 27ChondroGene Management Update
Aug 26ChondroGene Reports Second Quarter 2004 Financial Results
Aug 25ChondroGene Completes US$5 Million Private Placement Through Rodman & Renshaw
Aug 12Genetic Marker Paper Published in Circulation
Aug 10ChondroGene Announces Private Placement
Aug 4ChondroGene Announces the Issuance of Stock Options
Aug 3First Comprehensive Mapping of Cartilage Transcripts Paper Published in Genomics
Jul 27Paper Published in Landmark Textbook: Molecular Basis of Cardiovascular Disease
May 31ChondroGene Reports First Quarter 2004 Financial Results
May 31ChondroGene Announces the Issuance of Stock Options
Apr 16ChondroGene Reports 2003 Year End Financial Results
Jan 29ChondroGene Announces Appointment of Dr. Victor Dzau as Scientific Advisor
Jan 27ChondroGene Provides Update on Pfizer Collaboration

2003

Dec 2ChondroGene and the Canadian Arthritis Network Enter into Research Collaboration
Nov 28ChondroGene Limited Reports Third Quarter 2003 Financial Results
Nov 27ChondroGene Completes GeneNews Acquisition
Aug 28ChondroGene Limited Reports Second Quarter 2003 Financial Results
Jun 27ChondroGene Announces the Issuance of Stock Options
Jun 27Dr. Thomas Yager Joins ChondroGene As Director of Product Development & QA
Jun 23GeneNews Acquisition Update
Jun 16ChondroGene Completes $3 Million Private Placement
Jun 2ChondroGene Reports Record First Quarter Financial Results
May 26ChondroGene Closes on $2 Million of Private Placement
May 16ChondroGene to Acquire GeneNews Inc.
Apr 29ChondroGene Announces $3 Million Private Placement
Apr 9ChondroGene Provides Update on Pfizer Collaboration
Apr 4Dr. Frank Barry Appointed to ChondroGene's Advisory Board
Apr 1Bruno Maruzzo Joins Chondrogene In Corporate Development Role

2002

Oct 10ChondroGene Announces Collaboration with Pfizer
Mar 26Rory Riggs Appointed Chair of ChondroGene Board
Jan 17Strong Demand in ChondroGene Rights Offering

2001

Dec 10ChondroGene to Proceed with Rights Offering
Dec 6Dr. Wayne Marshall to Become President of ChondroGene effective Jan 1, 2002
Aug 14Dr. Dan Grande to Join ChondroGene's Scientific Advisory Board
Jul 23ChondroGene and Genzyme Biosurgery Enter Into Genomics Collaboration on Human Cartilage
Jun 20ChondroGene Completes Comprehensive Sequencing of Cartilage Genes
Jan 2ChondroGene Shares to Commence Trading on The Canadian Venture Exchange

2000

Dec 22ChondroGene Purchases Intellectual Property Rights for Blood Sample Osteoarthritis Test
Jun 2ChondroGene Changes Name
May 11Lewis Brook Resources Ltd and ChondroGene Amalgamation Agreement